G6PD deficiency and stroke in the CSSCD

American Journal of Hematology

Volumn 86, Issue 3, 2011, Pages 331-331

  Miller, Scott T ^a   Milton, Jacqueline ^b   Steinberg, Martin H ^c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

DOPPLER ECHOGRAPHY; ENDOTHELIUM CELL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMAN; INFECTION; LETTER; PAIN; PRIORITY JOURNAL; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; STROKE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANEMIA, SICKLE CELL; DATABASES, FACTUAL; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; STROKE;

EID: 79951911507     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21958     Document Type: Letter

References (9)

1. Steinberg MH, West MS, Gallagher D, Mentzer W. Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia. Blood 1988; 71: 748-752.
2. Mejias R, Villadiego J, Pintado CO, et al. Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice. J Neurosci 2006; 26: 4500-4508.
3. Rachna Agarwal AR. Redistribution of glucose-6-phosphate dehydrogenase in response to cerebral ischemia in rat brain. Indian J Clin Biochem 2003; 18: 64-70.
4. Leopold JA, Cap A, Scribner AW, et al. Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J 2001; 15: 1771-1773.
5. Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 1332-1340.
6. Matsui R, Xu S, Maitland KA, et al. Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II. Circulation 2005; 112: 257-263.
7. Bernaudin F, Verlhac S, Chevret S, et al. G6PD deficiency, absence of alpha-thalassemia and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood 2008; 112: 4314-4317.
8. Rees DC, Lambert C, Cooper E, et al. Glucose 6 phosphate dehydrogenase deficiency is not associated with cerebrovascular disease in children with sickle cell anemia. Blood 2009; 114: 742-743; author reply 743-744.
9. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998; 91: 288-294.